GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, firstname.lastname@example.org
#12501 Anti-DNA and RNA Oxidative Damage Markers
Product name : Anti-DNA and RNA Oxidative Damage Markers
Catalog number : 12501
Supplier name : QED
Data sheet: Ask more or other datasheet now !
About this Product :Anti-DNA and RNA Oxidative Damage Markers rna research rna is not so stable and very sticky. Rnases are abundand on hans and everywhere. SoreRNA at -75C and use rnase free.
More Details about
Luciferin is the most popular and versatile bioluminescent substrate. The firefly luciferase/luciferin bioluminescent system is found in the firefly (Photinus pyralis) and several other beetles. Luciferase oxidizes ATP-activated luciferin through a dioxetanone intermediate. Firefly luciferase produces light by the ATP-dependent oxidation of luciferin. The 560 nm chemiluminescence from this reaction peaks within seconds, with light output that is proportional to luciferase activity when luciferin and ATP are present in excess. Firefly luciferase has long been conjugated to antibodies and used as a label in immunoassays using luciferin as the substrate for detection. Compared to HRP and alkaline phosphatase, luciferase is less tolerant to chemical modifications. One particular advantage to the enzyme is that there is low endogenous luciferase activity in mammalian tissues besides its high sensitivity. Another important use of luciferase is in the area of hygiene monitoring. The luciferase/luciferin system can be used to detect contamination because ATP, present in all living organisms, is required to produce luminescence. The main application for this type of ATP bioluminescence is quality assurance by testing surfaces in food processing plants to determine whether or not there is contamination of either equipment or products.
Contact us about this product :
Our team will respond you as soon as possible !
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
email@example.com | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
WP1496: Oxidative Damage
WP1050: Oxidative Stress
WP1110: Oxidative phosphorylation
WP1166: Oxidative Stress
WP1248: Oxidative phosphorylation
WP1283: Oxidative phosphorylation
WP1335: Oxidative phosphorylation
WP1372: Oxidative Stress
WP1530: miRNA regulation of DNA Damage Response
WP1579: DNA damage response
WP1680: Oxidative phosphorylation
WP173: Oxidative Stress
WP1803: DNA Damage Bypass
WP1804: DNA Damage Reversal
WP1963: The effect of Glucocorticoids on target gene expression
WP2087: miRNA regulation of DNA Damage Response
WP2271: Macrophage markers
WP379: Non-Oxidative Branch of the Pentose Pathway
WP408: Oxidative Stress
WP412: Oxidative Stress
WP417: Oxidative Branch of the Pentose Phosphate Pathway
WP623: Oxidative phosphorylation
WP707: DNA damage response
WP710: DNA damage response (only ATM dependent)
WP766: Oxidative phosphorylation
Related Genes :
[TP53 P53] Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)
[DNA2 DNA2L KIAA0083] DNA replication ATP-dependent helicase/nuclease DNA2 (hDNA2) (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 22.214.171.124)]
[MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A] Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 126.96.36.199) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a)
[DNA2 YHR164C] DNA replication ATP-dependent helicase/nuclease DNA2 [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 188.8.131.52)]
[BCL2] Apoptosis regulator Bcl-2
[rseA mclA yfiJ b2572 JW2556] Anti-sigma-E factor RseA (Regulator of SigE) (Sigma-E anti-sigma factor RseA) (Sigma-E factor negative regulatory protein)
[rsrA SCO5217] Anti-sigma factor RsrA (Regulator of SigR) (Sigma-R anti-sigma factor RsrA)
[dna2 SPBC16D10.04c] DNA replication ATP-dependent helicase/nuclease dna2 [Includes: DNA replication nuclease dna2 (EC 3.1.-.-); DNA replication ATP-dependent helicase dna2 (EC 184.108.40.206)]
[BCAR1 CAS CASS1 CRKAS] Breast cancer anti-estrogen resistance protein 1 (CRK-associated substrate) (Cas scaffolding protein family member 1) (p130cas)
[rep 1a-1b] Replicase polyprotein 1ab (pp1ab) (ORF1ab polyprotein) [Cleaved into: Host translation inhibitor nsp1 (nsp1) (Leader protein); Non-structural protein 2 (nsp2) (p65 homolog); Papain-like proteinase (PL-PRO) (EC 220.127.116.11) (EC 18.104.22.168) (Non-structural protein 3) (nsp3) (PL2-PRO) (SARS coronavirus main proteinase); Non-structural protein 4 (nsp4); 3C-like proteinase (3CL-PRO) (3CLp) (EC 3.4.22.-) (nsp5); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7); Non-structural protein 8 (nsp8); Non-structural protein 9 (nsp9); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL); RNA-directed RNA polymerase (Pol) (RdRp) (EC 22.214.171.124) (nsp12); Helicase (Hel) (EC 126.96.36.199) (EC 188.8.131.52) (nsp13); Guanine-N7 methyltransferase (ExoN) (EC 2.1.1.-) (EC 3.1.13.-) (nsp14); Uridylate-specific endoribonuclease (EC 3.1.-.-) (NendoU) (nsp15); 2'-O-methyltransferase (EC 2.1.1.-) (nsp16)]
[MLH1 COCA2] DNA mismatch repair protein Mlh1 (MutL protein homolog 1)
[Bcl2 Bcl-2] Apoptosis regulator Bcl-2
[Dna2 Dna2l Kiaa0083] DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 184.108.40.206)]
[AMHR2 AMHR MISR2] Anti-Muellerian hormone type-2 receptor (EC 220.127.116.11) (Anti-Muellerian hormone type II receptor) (AMH type II receptor) (MIS type II receptor) (MISRII) (MRII)
[MSH2] DNA mismatch repair protein Msh2 (hMSH2) (MutS protein homolog 2)
[ASF1 CIA1 YJL115W J0755] Histone chaperone ASF1 (Anti-silencing function protein 1) (yASF1)
[chrR RHOS4_27110 RSP_1093] Anti-sigma-E factor ChrR (Sigma-E anti-sigma factor ChrR) (Transcriptional activator ChrR)
[dna2 dna2l] DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 18.104.22.168)]
[OTUD7B ZA20D1] OTU domain-containing protein 7B (EC 22.214.171.124) (Cellular zinc finger anti-NF-kappa-B protein) (Cezanne) (Zinc finger A20 domain-containing protein 1) (Zinc finger protein Cezanne)
[MCM10 DNA43 YIL150C] Minichromosome maintenance protein 10 (Protein DNA43)
 Cytochrome c oxidase subunit 1 (EC 126.96.36.199) (Fragment)
[BTG2 PC3] Protein BTG2 (BTG family member 2) (NGF-inducible anti-proliferative protein PC3)
[DNA2 DNA2L RCJMB04_11a16] DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 188.8.131.52)]
 Genome polyprotein [Cleaved into: Core protein p21 (Capsid protein C) (p21); Core protein p19; Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); p7; Protease NS2-3 (p23) (EC 3.4.22.-); Serine protease NS3 (EC 184.108.40.206) (EC 220.127.116.11) (EC 18.104.22.168) (Hepacivirin) (NS3P) (p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56); RNA-directed RNA polymerase (EC 22.214.171.124) (NS5B) (p68)]
[NFKB1] Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit]
 Genome polyprotein [Cleaved into: P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); P2; Protease 2A (P2A) (EC 126.96.36.199) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 188.8.131.52); P3; Protein 3AB; Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 184.108.40.206); Protease 3C (P3C) (EC 220.127.116.11); RNA-directed RNA polymerase (RdRp) (EC 18.104.22.168) (3D polymerase) (3Dpol) (Protein 3D) (3D)]
[RAD51 RAD51A RECA] DNA repair protein RAD51 homolog 1 (HsRAD51) (hRAD51) (RAD51 homolog A)
[Amhr2] Anti-Muellerian hormone type-2 receptor (EC 22.214.171.124) (Anti-Muellerian hormone type II receptor) (AMH type II receptor) (C14) (MIS type II receptor) (MISRII) (MRII)
[rslA Rv0736] Anti-sigma-L factor RslA (Regulator of SigL) (Sigma-L anti-sigma factor RslA)
[TNFAIP3 OTUD7C] Tumor necrosis factor alpha-induced protein 3 (TNF alpha-induced protein 3) (EC 126.96.36.199) (EC 6.3.2.-) (OTU domain-containing protein 7C) (Putative DNA-binding protein A20) (Zinc finger protein A20) [Cleaved into: A20p50; A20p37]
 Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination.
 Zinc complexes of diflunisal: Synthesis, characterization, structure, antioxidant activity, and in vitro and in silico study of the interaction with DNA and albumins.
 Engineering of Anti-CD133 Tri-Specific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC).
 Rapid generation of drug-resistance alleles at endogenous loci using CRISPR-Cas9 indel mutagenesis.
 Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals.
 A Novel Mutation in the Pyrin Domain of the NOD-like Receptor Family Pyrin Domain Containing Protein 3 in Muckle-Wells Syndrome.
 Circulating-free DNA Mutation Associated with Response of Targeted Therapy in Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer.
 Cardiovascular complications in paediatric-onset systemic lupus erythematosus in Saudi Arabian patients.
 DNA methylation data for identification of epigenetic targets of resveratrol in triple negative breast cancer cells.
 Schizophrenia Associated with Epileptiform Discharges without Seizures Successfully Treated with Levetiracetam.
Enter catalog number :